Allen James Meglin Organicell Regenerative Medicine, Inc. (OCEL) insider trading activity
Allen James Meglin is Director of Organicell Regenerative Medicine, Inc.. Currently has a direct ownership of 14.6 Million shares of OCEL, which is worth approximately $16.8 Million. The most recent transaction as insider was on Dec 21, 2020, when has been sold 1,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14.6M
0%
3M change
0%
12M change
Total Value Held
$16.8 Million
Allen James Meglin Transaction History
AJM
Allen James Meglin
Director
Savannah, GA